Last update :
28/04/2024
Anticancer drug   Aflibercept  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Zaltrap Belgium, Brazil, Canada, Chile, Denmark, Ecuador, Finland, France, Germany, Great Britain, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Peru, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United States of America
Zaltrapziv Mexico
Stability in solutions   Injection   Stability in solutions : Aflibercept     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,6 >> 8 mg/ml 2-8°C Not specified
24 Hour
3508
Manufacturer's stability data

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,6 >> 8 mg/ml 25°C Light
8 Hour
3508
Manufacturer's stability data

Polyolefine NaCl 0,9% or Glucose 5% 0,6 >> 8 mg/ml 2-8°C Not specified
24 Hour
3508
Manufacturer's stability data

Polyolefine NaCl 0,9% or Glucose 5% 0,6 >> 8 mg/ml 25°C Light
8 Hour
3508
Manufacturer's stability data

Polyolefine Sodium chloride 0,9% 0,6 mg/ml 2-8°C Protect from light
14 Day
4728
Level of evidence A+

Polyolefine Sodium chloride 0,9% 4 mg/ml 2-8°C Protect from light
14 Day
4728
Level of evidence A+

Polypropylen Syringe None 40 mg/ml 4°C Protect from light
30 Day
4798

  Mentions Légales